Mad in America
APRIL 2, 2025
What began as a wonderful career combining my scientific knowledge with creative writing gradually revealed itself as something far more troubling: I was helping to manufacture “facts” about diseases and treatments that would shape medical practice for decades. reporting receiving treatment for depression in 2023.The
Mad in America
APRIL 3, 2025
O n 20 January 2025, I notified the UK drug regulator, the Medicines & Healthcare products Regulatory Agency (MHRA) that the package inserts for antidepressantscalled patient information leaflets (PIL)contain false statements about depression being caused by a chemical imbalance. ” Two months later, the MHRA responded.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Psychiatric Times
JULY 1, 2025
Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur. Clinical trials reveal higher plasma exposure and adverse effects in younger children, questioning the benefit-risk balance of these medications.
Mad in America
FEBRUARY 20, 2024
What’s concerning is that despite the significant impact of sexual dysfunction on patients’ quality of life, many did not discuss these issues with their healthcare providers. at the time of the study, indicating affiliations with pharmaceutical companies that manufacture antidepressants, including those under investigation.
Mad in America
NOVEMBER 13, 2023
In evidence-based healthcare, we do not use interventions that do more harm than good, which psychiatry does. Avoid financial conflicts of interest with manufacturers of psychoactive drugs or other treatments, e.g. equipment for electroshock. They are not medical diseases. Consider involving recovery mentors who have lived experience.
Center for Integrative Psychiatry
APRIL 22, 2025
It’s delivered as a nasal spray and must be administered in a certified healthcare setting. As you progress, the frequency of sessions may be adjusted based on your unique journey and the recommendations of your healthcare provider. Some manufacturers also offer assistance programs to help with costs. The answer is yes.
Mad in America
APRIL 6, 2024
Paradoxical’, because in contrast with healthcare outcomes generally being better in ‘developed’ (high income) countries, outcomes for those who had suffered psychosis were apparently better in the ‘developing’, lower and middle income countries. China, obviously, has its own large manufacturing capacity.
Expert insights. Personalized for you.
142 
Let's personalize your content